Evidence map›Paper›PMID 34832905›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

The Natural Combination Medicine Traumeel (Tr14) Improves Resolution of Inflammation by Promoting the Biosynthesis of Specialized Pro-Resolving Mediators.

Paul M Jordan, Emeline van Goethem, Andrea M Müller, Kathrin Hemmer, Virginie Gavioli, Vincent Baillif, Yvonne Burmeister, Natascha Krömmelbein, Marc Dubourdeau, Bernd Seilheimer and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. [Infiltration therapies for lateral epicondylopathy].Orthopadie (Heidelberg, Germany) · 2023
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Paul M JordanDepartment of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena, Philosophenweg 14, 07743 Jena, Germany.ORCID 0000-0002-8364-4236
Emeline van GoethemAmbiotis SAS, 3 Rue des Satellites, 31400 Toulouse, France.
Andrea M MüllerHeel GmbH, Dr. Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany.
Kathrin HemmerHeel GmbH, Dr. Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany.
Virginie GavioliAmbiotis SAS, 3 Rue des Satellites, 31400 Toulouse, France.
Vincent BaillifAmbiotis SAS, 3 Rue des Satellites, 31400 Toulouse, France.
Yvonne BurmeisterHeel GmbH, Dr. Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany.
Natascha KrömmelbeinHeel GmbH, Dr. Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany.
Marc DubourdeauAmbiotis SAS, 3 Rue des Satellites, 31400 Toulouse, France.
Bernd SeilheimerHeel GmbH, Dr. Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany.
Oliver WerzDepartment of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena, Philosophenweg 14, 07743 Jena, Germany.ORCID 0000-0002-5064-4379
Heel (Germany) · DEFriedrich Schiller University Jena · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The resolution of inflammation is an integral part of the acute inflammatory response and eventually leads to the return to homeostasis. It is supported by specialized pro-resolving mediators (SPMs) that act as immunoresolvents via specific G-protein-coupled receptors. In contrast to classical non-steroidal anti-inflammatory drugs (NSAIDs) that suppress the formation of pro-inflammatory lipid mediators such as prostaglandins, novel pharmacotherapeutic concepts propose to foster the biosynthesis of beneficial SPMs. Here, we demonstrate that the natural combination medicine Traumeel (Tr14) improves resolution of inflammation by promoting SPM formation. Tr14 enhanced the biosynthesis of 12-/15-lipoxygenase (LOX) products and of SPMs in zymosan-induced mouse peritonitis as well as in human monocyte-derived macrophages challenged with

Indexed as

efferocytosisinflammationinflammation resolutionlipid mediatormulticomponentperitonitisresolution indexspecialized pro-resolving mediatorsTraumeel

Identifiers

PMID34832905
PMCPMC8623904
OpenAlexW3210831701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.